News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Johann de Bono and Mateus Crespo Prostate cancer cells 547x410
Major trial shows breast cancer drug can hit prostate cancer Achilles heel

28/04/20

A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.
Group shot of #teamICR runners
Training for a marathon in a pandemic: the fundraisers helping us finish cancer

26/04/20

As sports events around the world are put on hold in the midst of the coronavirus crisis, Joanne Duffy finds out how #teamICR have come together to support each other, adapt their training and focus on what really matters to them.
Sir Richard Doll building in Sutton
Our COVID-19 research and how we’re supporting the NHS

21/04/20

Staff and students from across The Institute of Cancer Research, London, are using their scientific and clinical expertise as part of the national response to the coronavirus pandemic.
HSP72 target 547x410
Scientists enhance new way to overcome resistance to targeted cancer treatments

06/04/20

Researchers have enhanced a new method for inhibiting the protein HSP72, known to be important in helping cancer cells survive and resist treatment, which will help scientists move closer to discovering a new cancer drug that targets the protein.
ICR Logo
Babies with brain tumours could benefit from targeted treatment

02/04/20

Brain cancer in infants is biologically distinct from other childhood brain tumours and could be successfully treated with targeted drugs, a new study has shown.
An MRI scanner
Major new cancer imaging network involving the ICR and The Royal Marsden established

28/03/20

Nine world-leading medical imaging centres from across the UK will come together to form an integrated network for standardising and validating the use of cutting-edge imaging techniques in cancer treatment.
The ICR logo on the Brookes Lawley Building
Latest coronavirus update - 25 March

25/03/20

The Institute of Cancer Research, London, has now ceased most of its ‘wet lab’ research as part of a series of measures to safeguard staff and students from coronavirus – but we are proud to be supporting the national effort against the pandemic.
The ICR logo on the Brookes Lawley Building
Latest coronavirus update - 20 March

20/03/20

The Institute of Cancer Research, London, is putting in place a series of measures to safeguard its staff and students in response to the coronavirus pandemic, while also seeking to minimise the long-term impact upon our life-saving research.
The ICR logo on the Brookes Lawley Building
Latest ICR update concerning coronavirus - 17 March

17/03/20

The Institute of Cancer Research, London, is doing everything it can to safeguard its staff and students in response to the coronavirus pandemic while attempting to minimise the inevitable disruption to its life-saving research.
The ICR logo on the Brookes Lawley Building
ICR updates on its response to coronavirus - 14 March

14/03/20

The Institute of Cancer Research, London, is continuing to do its life-saving cancer research in line with Government guidance on coronavirus while making extensive preparations for disruption ahead.
ICR Logo
Weight gain linked to lower risk of breast cancer before the menopause

13/03/20

Gaining weight from early adulthood is linked to a lower risk of breast cancer before the menopause, a major global study of more than 600,000 women has found.
ICR Logo
Two-pronged attack on DNA repair could kill drug-resistant cancers

12/03/20

Launching a two-pronged attack on cancer’s ability to safeguard its DNA could offer an effective new way of treating the disease, a new study reports.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.